Trademark Overview
On Thursday, October 30, 2025, a trademark application was filed for AWESMARI with the United States Patent and Trademark Office. The USPTO has given the AWESMARI trademark a serial number of 99471959. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 4, 2026. This trademark is owned by Amgen Inc.. The AWESMARI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases, blood diseases, bone and skeletal diseases, cancer, cardiovascular diseases, sleep apnea, central nervous system diseases, cluster headaches, coronavirus disease, and Crohn's disease; Pharmaceutical preparations for treating dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammatory diseases and disorders, kidney diseases, liver diseases, lupus, and mental disorders; Pharmaceutical preparations for treating metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative or neurological diseases and disorders, obesity, chronic weight management, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases; Pharmaceutical preparations
